Literature DB >> 24587626

Helicobacter pylori and skin autoimmune diseases.

Eli Magen1, Jorge-Shmuel Delgado1.   

Abstract

Autoimmune skin diseases are characterized by dysregulation of the immune system resulting in a loss of tolerance to skin self-antigen(s). The prolonged interaction between the bacterium and host immune mechanisms makes Helicobacter pylori (H. pylori) a plausible infectious agent for triggering autoimmunity. Epidemiological and experimental data now point to a strong relation of H. pylori infection on the development of many extragastric diseases, including several allergic and autoimmune diseases. H. pylori antigens activate cross-reactive T cells and induce autoantibodies production. Microbial heat shock proteins (HSP) play an important role of in the pathogenesis of autoimmune diseases because of the high level of sequence homology with human HSP. Eradication of H. pylori infection has been shown to be effective in some patients with chronic autoimmune urticaria, psoriasis, alopecia areata and Schoenlein-Henoch purpura. There is conflicting and controversial data regarding the association of H. pylori infection with Behçet's disease, scleroderma and autoimmune bullous diseases. No data are available evaluating the association of H. pylori infection with other skin autoimmune diseases, such as vitiligo, cutaneous lupus erythematosus and dermatomyositis. The epidemiological and experimental evidence for a possible role of H. pylori infection in skin autoimmune diseases are the subject of this review.

Entities:  

Keywords:  Autoimmune; Helicobacter pylori; Infection; Skin

Mesh:

Year:  2014        PMID: 24587626      PMCID: PMC3925859          DOI: 10.3748/wjg.v20.i6.1510

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

Review 1.  Clinical practice. Helicobacter pylori infection.

Authors:  Kenneth E L McColl
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

4.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

Review 5.  Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system.

Authors:  Ali Shakouri; Enrico Compalati; David M Lang; David A Khan
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-08

6.  Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome.

Authors:  R Blanco; V M Martínez-Taboada; V Rodríguez-Valverde; M García-Fuentes; M A González-Gay
Journal:  Arthritis Rheum       Date:  1997-05

7.  TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells.

Authors:  Ayca Sayi; Esther Kohler; Isabella M Toller; Richard A Flavell; Werner Müller; Axel Roers; Anne Müller
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

8.  Assessment of autoimmunity in patients with chronic urticaria.

Authors:  L J Tong; G Balakrishnan; J P Kochan; J P Kinét; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1997-04       Impact factor: 10.793

Review 9.  Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature.

Authors:  Lior Sagi; Sharon Baum; Nancy Agmon-Levin; Yaniv Sherer; Bat Sheva Porat Katz; Ori Barzilai; Maya Ram; Nicola Bizzaro; Marielle SanMarco; Henri Trau; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2011-04-16       Impact factor: 9.754

10.  Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.

Authors:  A Gasbarrini; I Massari; M Serricchio; P Tondi; A De Luca; F Franceschi; V Ojetti; A Dal Lago; R Flore; A Santoliquido; G Gasbarrini; P Pola
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

View more
  14 in total

Review 1.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

2.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

3.  Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer.

Authors:  Valli De Re; Ombretta Repetto; Stefania Zanussi; Mariateresa Casarotto; Laura Caggiari; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Infect Agent Cancer       Date:  2017-04-27       Impact factor: 2.965

4.  Helicobacter pylori-induced premature senescence of extragastric cells may contribute to chronic skin diseases.

Authors:  Anna Lewinska; Maciej Wnuk
Journal:  Biogerontology       Date:  2017-01-10       Impact factor: 4.277

5.  Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis.

Authors:  Priscila Miranda Diogo Mesquita; Augusto Diogo; Miguel Tanus Jorge; Alceu Luiz Camargo Villela Berbert; Sônia Antunes de Oliveira Mantese; José Joaquim Rodrigues
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

Review 6.  Helicobacter pylori and extragastric diseases: A review.

Authors:  Antonietta Gerarda Gravina; Rocco Maurizio Zagari; Cristiana De Musis; Lorenzo Romano; Carmelina Loguercio; Marco Romano
Journal:  World J Gastroenterol       Date:  2018-08-07       Impact factor: 5.742

7.  Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report.

Authors:  Guo-Qing Yang; Yi-Jun Li; Jing-Tao Dou; Bao-An Wang; Ju-Ming Lu; Yi-Ming Mu
Journal:  BMC Endocr Disord       Date:  2016-05-03       Impact factor: 2.763

Review 8.  Association between Psoriasis and Helicobacter pylori Infection: A Systematic Review and Meta-analysis.

Authors:  Wai Chung Yong; Sikarin Upala; Anawin Sanguankeo
Journal:  Indian J Dermatol       Date:  2018 May-Jun       Impact factor: 1.494

9.  Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases.

Authors:  Hyun Ho Hwang; In Seok Lim; Byung-Sun Choi; Dae Yong Yi
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

10.  Relationship between Helicobacter pylori infection and psoriasis: a nationwide population-based longitudinal cohort study.

Authors:  Meng-Che Wu; Kevin Sheng-Kai Ma; Huang-Hsi Chen; Jing-Yang Huang; James Cheng-Chung Wei
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.